<SEC-DOCUMENT>0001104659-23-060800-index.html : 20230515 <SEC-HEADER>0001104659-23-060800.hdr.sgml : 20230515 <ACCEPTANCE-DATETIME>20230515161755 ACCESSION NUMBER: 0001104659-23-060800 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230515 DATE AS OF CHANGE: 20230515 GROUP MEMBERS: KOH, BONG GROUP MEMBERS: SHAH, NIMISH GROUP MEMBERS: VENROCK HEALTHCARE CAPITAL PARTNERS EG, L.P. GROUP MEMBERS: VHCP CO-INVESTMENT HOLDINGS III, LLC GROUP MEMBERS: VHCP MANAGEMENT EG, LLC GROUP MEMBERS: VHCP MANAGEMENT III, LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: 4D Molecular Therapeutics, Inc. CENTRAL INDEX KEY: 0001650648 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473506994 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-91921 FILM NUMBER: 23922705 BUSINESS ADDRESS: STREET 1: 5858 HORTON STREET #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 5105052680 MAIL ADDRESS: STREET 1: 5858 HORTON STREET #455 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc. DATE OF NAME CHANGE: 20200506 FORMER COMPANY: FORMER CONFORMED NAME: 4D Molecular Therapeutics Inc DATE OF NAME CHANGE: 20150811 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Venrock Healthcare Capital Partners III, L.P. CENTRAL INDEX KEY: 0001738048 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 530 FIFTH AVENUE, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-444-4100 MAIL ADDRESS: STREET 1: 530 FIFTH AVENUE, 22ND FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>tm2315764d1_sc13g.htm <DESCRIPTION>SC 13G <TEXT> Document 1 - file: tm2315764d1_sc13g.htm
</DOCUMENT> </SEC-DOCUMENT>